In Light of the Opioid Epidemic, Pharmaceutical Companies Called Upon to Stop Marketing Opioid-Painkillers

Just last week, Purdue Pharma, a company well known for selling OxyContin, announced that they would stop marketing opioid drugs to doctors and pledged that it would cut its sales force by more than 50 percent, with approximately 200 people remaining in the department.

Public health and drug policy experts across the nation have been calling for pharmaceutical companies to stop marketing opiates to doctors as they cite over-prescribing as one of the fundamental flaws inhibiting progress to stop the opioid epidemic.

In a recent Harris Poll survey conducted with NPR, we found that while the CDC Guidelines state chances of opioid addiction “significantly increasing” after 5 days, our research revealed that nearly 90% say they have prescriptions that are longer and that the typical prescription length is actually 6 times that. In addition, nearly half of Americans reported to have taken prescription-based opioids, and about 1 in 3 Americans (31%) has personally experienced opioid dependency or abuse, whether it be themselves, a friend or family member who has or is currently struggling.

As the nation combats this crisis, America agrees more systemic policy change is needed, with (62%) of Americans agreeing that the opioid crisis cannot be solved alone in the streets of America and (52%) reporting that opioid overdoses and deaths are a far bigger crisis in America than reported on by the media.